Cargando…
Cornel iridoid glycoside ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by attenuating amyloid-beta, tau hyperphosphorylation and neurotrophic dysfunction
BACKGROUND: Targeted proteinopathy is involved in creating pharmacological agents that protect against Alzheimer disease (AD). Cornel iridoid glycoside (CIG) is an effective component derived from Cornus officinalis. The present study aimed to determine the effects of CIG on β-amyloid (Aβ) and tau p...
Autores principales: | Yang, Cuicui, Bao, Xunjie, Zhang, Li, Li, Yali, Li, Lin, Zhang, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186687/ https://www.ncbi.nlm.nih.gov/pubmed/32355772 http://dx.doi.org/10.21037/atm.2020.02.138 |
Ejemplares similares
-
The Reduction of Tau Hyperphosphorylation by Cornel Iridoid Glycosides Is Mediated by Their Influence on Calpain Activity
por: Guo, Kaiwen, et al.
Publicado: (2022) -
Cornel Iridoid Glycoside Attenuates Tau Hyperphosphorylation by Inhibition of PP2A Demethylation
por: Yang, Cui-cui, et al.
Publicado: (2013) -
Cornel Iridoid Glycoside Inhibits Tau Hyperphosphorylation via Regulating Cross-Talk Between GSK-3β and PP2A Signaling
por: Yang, Cuicui, et al.
Publicado: (2018) -
Cornel Iridoid Glycoside Protects Against STAT1-Dependent Synapse and Memory Deficits by Increasing N-Methyl-D-aspartate Receptor Expression in a Tau Transgenic Mice
por: Ma, Denglei, et al.
Publicado: (2021) -
Ellagic acid ameliorates learning and memory impairment in APP/PS1 transgenic mice via inhibition of β-amyloid production and tau hyperphosphorylation
por: Zhong, Lili, et al.
Publicado: (2018)